Market Overview

20 Stocks Moving In Monday's Pre-Market Session

Share:

Gainers

  • Westport Fuel Systems Inc (USA) (NASDAQ: WPRT) rose 34 percent to $1.42 in pre-market trading after the company reported the signing of a definitive agreement to sell its APU assets for $70 million.
  • Alere Inc (NYSE: ALR) rose 17 percent to $49.50 in pre-market trading. Abbott Laboratories (NYSE: ABT) agreed to buy Alere for $51 per share, versus its earlier offer of $56 per share.
  • Immune Pharmaceuticals Inc (NASDAQ: IMNP) shares rose 16.5 percent to $2.97 in pre-market trading after declining 2.67 percent on Thursday.
  • HTG Molecular Diagnostics Inc (NASDAQ: HTGM) rose 11.9 percent to $6.50 in pre-market trading on announcement that the company and Daiichi Sankyo have completed a master services agreement.
  • Catalyst Biosciences Inc (NASDAQ: CBIO) rose 10.2 percent to $5.96 in pre-market trading after climbing 2.46 percent on Thursday.
  • Moneygram International Inc (NASDAQ: MGI) rose 9.1 percent to $18.00 in pre-market trading after China's Ant Financial raised its bid for the company by 36 percent to $18 per share in cash.
  • Cameco Corp (USA) (NYSE: CCJ) rose 7.1 percent to $11.90 in pre-market trading after dropping 1.94 percent on Thursday.
  • Straight Path Communications Inc (NYSE: STRP) rose 7 percent to $98.10 in pre-market trading after falling 0.33 percent on Thursday. A report on Thursday mentioned that Verizon could top AT&T bid.
  • Norsat International Inc (USA) (NYSE: NSAT) shares rose 6.4 percent to $10.75 in pre-market trading. Privet Fund Management offered US$11 per share to acquire Norsat International.
  • Pingtan Marine Enterprise Ltd (NASDAQ: PME) shares rose 5.4 percent to $4.90 in pre-market trading after gaining 5.92 percent on Thursday.
  • Nutanix Inc (NASDAQ: NTNX) rose 4.6 percent to $18.00 in pre-market trading after dropping 2.71 percent on Thursday.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

  • GWG Holdings Inc (NASDAQ: GWGH) fell 19.4 percent to $8.45 in pre-market trading after dropping 5.62 percent on Thursday.
  • Incyte Corporation (NASDAQ: INCY) fell 10.9 percent to $125.50 in pre-market trading. The FDA on Friday declined to approve Eli Lilly and Co and Incyte arthritis drug Olumiant. PiperJaffray downgraded Incyte from Overweight to Neutral.
  • Baxter International Inc (NYSE: BAX) shares fell 9.9 percent to $48.00 in the pre-market trading session. Baxter disclosed that one of its employees received a DoJ grand jury subpoena pursuant to criminal investigation.
  • Patheon NV (NYSE: PTHN) fell 9.8 percent to $23.26 in pre-market trading after dropping 1.04 percent on Thursday.
  • Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) fell 8.3 percent to $14.68 in pre-market trading. Chardan Capital reiterated Akari Therapeutics with a Sell and raised the price target from $5.00 to $6.50.
  • RH (NYSE: RH) shares fell 6.3 percent to $44.05 in pre-market trading after slipping 0.02 percent on Thursday.
  • SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) shares fell 5.7 percent to $9.05 in pre-market trading after dropping 1.03 percent on Thursday.
  • Eli Lilly and Co (NYSE: LLY) fell 5.2 percent to $81.41 in pre-market trading. The FDA on Friday declined to approve Eli Lilly and Incyte arthritis drug Olumiant. BMO Capital downgraded Eli Lilly from Market Perform to Underperform.
  • Texas Pacific Land Trust (NYSE: TPL) dropped 5.2 percent to $263.50 in pre-market trading after declining 5.91 percent on Thursday.
 

Related Articles (ABT + AKTX)

View Comments and Join the Discussion!

Posted-In: #PreMarket Gainers LosersNews Movers & Shakers Pre-Market Outlook Markets Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com